| Overcoming barriers for siRNA therapeutics: from bench to bedside MI Sajid, M Moazzam, S Kato, K Yeseom Cho, RK Tiwari Pharmaceuticals 13 (10), 294, 2020 | 131 | 2020 |
| siRNA Therapeutics for the Therapy of COVID-19 and Other Coronaviruses MI Sajid, M Moazzam, Y Cho, S Kato, A Xu, JJ Way, S Lohan, RK Tiwari Molecular Pharmaceutics 18 (6), 2105-2121, 2021 | 44 | 2021 |
| Understanding COVID-19: from origin to potential therapeutics M Moazzam, MI Sajid, H Shahid, J Butt, I Bashir, M Jamshaid, AN Shirazi, ... International journal of environmental research and public health 17 (16), 5904, 2020 | 32 | 2020 |
| Applications of amphipathic and cationic cyclic cell-penetrating peptides: Significant therapeutic delivery tool MI Sajid, M Moazzam, R Stueber, SE Park, Y Cho, RK Tiwari Peptides 141, 170542, 2021 | 15 | 2021 |
| The landscape of nanoparticle-based siRNA delivery and therapeutic development M Moazzam, M Zhang, A Hussain, X Yu, J Huang, Y Huang Molecular Therapy 32 (2), 284-312, 2024 | 3 | 2024 |
| Constituents of Cosmeceuticals and Implication of Nanotechnology in Cosmetics M Moazzam, T Mehboob, I Bashir, R Aslam, N Tabassam, M Jamshaid RADS Journal of Pharmacy and Pharmaceutical Sciences 6 (4), 270-281, 2018 | | 2018 |
Dr. Rakesh Kumar Tiwari, Associate Pr...Western University of Health Sciences, College of Osteopathic Medicine of PacificVerified email at westernu.edu
